Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating safety, tolerability, pharmacokinetics and preliminary efficacy of ASC30 Tablets and ASC30 Tablets A1 in adults with ob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ASC30 Tablets (ASC30)
• ASC30 Tablets A1

Snippet

Sponsor: Ascletis Pharma (China) Co., Limited | Conditions: Weight Management | Phase 1 | Status: COMPLETED